论文部分内容阅读
此前研究证实将低密度脂蛋白(LDL)胆固醇降至目前推荐水平以下对急性冠脉综合征患者有益,但将LDL降至何等水平为宜尚无定论。本研究的目的旨在前瞻性地分析稳定性冠心病(CHD)患者LDL胆固醇水平降至低于2．6 mmol/L的效果和安全性。
Earlier studies confirmed that lowering LDL cholesterol below the currently recommended level may benefit patients with acute coronary syndromes, but it is not conclusive whether the level of LDL is reduced. The purpose of this study was to prospectively analyze the efficacy and safety of lowering LDL cholesterol levels below 2.6 mmol / L in patients with stable coronary heart disease (CHD).